• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
BMY

BMY

Bristol-Myers Squibb Company

NYSEHealthcareDrug Manufacturers - GeneralUS

USD54.72

+0.26 (+0.48%)

Rating:B+

Company Profile

CEO

Christopher S. Boerner

IPO Date

1972-06-01

Sector

Healthcare

Industry

Drug Manufacturers - General

Exchange

NYSE

Country

US

Market Metrics

Open

$54.56

Prev. Close

$54.46

Day Low

$54.31

Day High

$55.09

52W Low

$42.52

52W High

$62.89

Market Cap

$111.74B

Volume

8.44M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

55.4%

Avg Negative

9.3%

Avg Neutral

35.4%

News Feed

Bristol-Myers Squibb Is Quietly Building Its Next Growth Cycle

seekingalpha.com·5/27/2026·↑ positive

Bristol Myers Squibb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

businesswire.com·5/27/2026·↑ positive

Looking to Buy Bristol Myers Squibb Stock on the Dip? Read This First.

fool.com·5/24/2026·↑ positive

Bristol Myers Squibb to Unveil New Data at ASCO® 2026 Demonstrating Strength and Breadth of Scientific Innovation Across Oncology Portfolio and Next-Generation Pipeline

businesswire.com·5/21/2026·↑ positive

The Most Undervalued Healthcare Stock in the S&P 500 Right Now

fool.com·5/21/2026·↓ negative

Bristol Myers to deploy Anthropic's Claude AI model to speed up drug discovery

reuters.com·5/20/2026·↑ positive

Bristol Myers Squibb Announces Strategic Agreement with Anthropic to Position Claude Enterprise as the Shared Intelligence Platform Across Its Global Operations

businesswire.com·5/20/2026·↑ positive

Bristol-Myers Squibb Brings Anthropic's Claude to 30,000 of Its Staff

wsj.com·5/20/2026·↑ positive

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

benzinga.com·5/19/2026·↑ positive

Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration

cnbc.com·5/15/2026·↑ positive